Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 19533657

Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2009 Oct
First author
Kuttesch JF Jr

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Kuttesch JF Jr
      type
      Author
    2. name
      Krailo MD
      type
      Author
    3. name
      Madden T
      type
      Author
    4. name
      Johansen M
      type
      Author
    5. name
      Bleyer A
      type
      Author
    6. name
      Children's Oncology Group
      type
      CollectiveName
    Complete bibliographic record and source provenance
    authors
    1. name
      Kuttesch JF Jr
      type
      Author
    2. name
      Krailo MD
      type
      Author
    3. name
      Madden T
      type
      Author
    4. name
      Johansen M
      type
      Author
    5. name
      Bleyer A
      type
      Author
    6. name
      Children's Oncology Group
      type
      CollectiveName
    bibliography ids
    1. nci-bib-c45be355aafb0258a4a88fda
    book metadata
    content sha256
    65401a65f460a7a4d915db5585625229b7b26114001d1deec37b481a9265dfa5
    document type
    citation
    dois
    1. 10.1002/pbc.22133
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:19533657
    immutable id
    pubmed:19533657@65401a65f460a7a4d915db5585625229b7b26114001d1deec37b481a9265dfa5
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    4
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    590-3
    volume
    53
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      19533657
      provenance
      batch id
      4f803f1a8e7b4f56d2f1
      provider
      NCBI PubMed ESummary
      record sha256
      5142d001e731d8435a12b2798406f90f1128bb755f61d7b5354f0ddadfdacb17
      response sha256
      fddd7745d591ed24e15d20ce21f0a6c14874b8cee29153ff89c9892037c40127
      retrieved at
      2026-09-09T23:46:26.391289+00:00
      publication date
      display
      2009 Oct
      precision
      month
      year
      2009
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/19533657/
      title
      Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study.

      Preserved source evidence · Not medical advice